




Entertainment
View All
Arden Theatre Brings ‘Dear Evan Hansen’ to Philadelphia With Fresh, Modern Vision
PHILADELPHIA, PA — One of Broadway’s most talked-about musicals is set to take center stage in Old City, bringing a powerful story of connection, identity, and the impact of social …
Lifestyle
View All
Kemblesville: Where Time Lingers Along Route 896
The road narrows almost without warning. One moment, you’re moving through the open sweep of southern Chester County—fields stretching toward the horizon, the hum of tires on asphalt—and the next, …
Pennsylvania
View All
Traffic Deaths Hit Record Low in PA, But Risks Remain
HARRISBURG, PA — Traffic fatalities in Pennsylvania dropped to their lowest level on record in 2025, even as officials warn that risky driving behaviors continue to pose serious dangers on …
National
View All
Housing Rule Reversal Could Cut New Home Costs by $20K
WASHINGTON, D.C. — A federal policy change will allow more newly built homes to qualify for government-backed mortgages, after officials rescinded an energy standard they say raised construction costs and …
Latest Articles
View AllCabaletta, Cellares Sign Manufacturing Deal for Rese-Cel Supply
PHILADELPHIA, PA & SOUTH SAN FRANCISCO, CA — Cabaletta Bio, Inc. (Nasdaq: CABA) and Cellares have entered a commercial agreement to manufacture rese-cel, an investigational cell therapy for autoimmune diseases, …
Housing Rule Reversal Could Cut New Home Costs by $20K
WASHINGTON, D.C. — A federal policy change will allow more newly built homes to qualify for government-backed mortgages, after officials rescinded an energy standard they say raised construction costs and …
Annovis Bio Publishes Phase 2/3 Alzheimer’s Trial Results
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) recently published results from a Phase 2/3 clinical trial evaluating its investigational drug buntanetap in patients with mild to moderate Alzheimer’s disease, …
Aclaris Reports Phase 1a Results for ATI-052, Advances Pipeline
WAYNE, PA — Aclaris Therapeutics, Inc. (Nasdaq: ACRS) reported full results from a Phase 1a clinical trial of its ATI-052 antibody and outlined plans to advance multiple programs, including selecting …
Environmental Tectonics Corp. Secures $31M in Aerospace Contracts
SOUTHAMPTON, PA — Environmental Tectonics Corporation (OTC Pink: ETCC) has been awarded approximately $31 million in contracts to deliver aircrew training systems to two international customers, along with additional contracts …
